PMC:7408073 / 16837-17081 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T107","span":{"begin":80,"end":85},"obj":"Body_part"},{"id":"T108","span":{"begin":159,"end":167},"obj":"Body_part"}],"attributes":[{"id":"A107","pred":"fma_id","subj":"T107","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A108","pred":"fma_id","subj":"T108","obj":"http://purl.org/sig/ont/fma/fma62851"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T33","span":{"begin":80,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"uberon_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"LitCovid-PubTator","denotations":[{"id":"747","span":{"begin":6,"end":10},"obj":"Gene"},{"id":"886","span":{"begin":231,"end":237},"obj":"Gene"},{"id":"907","span":{"begin":58,"end":85},"obj":"Disease"},{"id":"908","span":{"begin":113,"end":135},"obj":"Disease"},{"id":"909","span":{"begin":219,"end":229},"obj":"Disease"}],"attributes":[{"id":"A747","pred":"tao:has_database_id","subj":"747","obj":"Gene:302668"},{"id":"A886","pred":"tao:has_database_id","subj":"886","obj":"Gene:24179"},{"id":"A907","pred":"tao:has_database_id","subj":"907","obj":"MESH:D009203"},{"id":"A908","pred":"tao:has_database_id","subj":"908","obj":"MESH:D002318"},{"id":"A909","pred":"tao:has_database_id","subj":"909","obj":"MESH:D013927"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T132","span":{"begin":58,"end":79},"obj":"Disease"},{"id":"T133","span":{"begin":113,"end":135},"obj":"Disease"},{"id":"T134","span":{"begin":219,"end":229},"obj":"Disease"}],"attributes":[{"id":"A132","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"},{"id":"A133","pred":"mondo_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"},{"id":"A134","pred":"mondo_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T185","span":{"begin":11,"end":19},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T186","span":{"begin":80,"end":85},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T187","span":{"begin":80,"end":85},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T188","span":{"begin":80,"end":85},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T189","span":{"begin":80,"end":85},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T190","span":{"begin":87,"end":89},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T110","span":{"begin":231,"end":234},"obj":"Chemical"},{"id":"T111","span":{"begin":235,"end":237},"obj":"Chemical"}],"attributes":[{"id":"A110","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A111","pred":"chebi_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T20","span":{"begin":181,"end":192},"obj":"http://purl.obolibrary.org/obo/GO_0050817"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"LitCovid-sentences","denotations":[{"id":"T84","span":{"begin":92,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T24","span":{"begin":58,"end":79},"obj":"Phenotype"},{"id":"T25","span":{"begin":113,"end":135},"obj":"Phenotype"}],"attributes":[{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0001658"},{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0001626"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}

{"project":"2_test","denotations":[{"id":"32708755-20797602-20678704","span":{"begin":87,"end":89},"obj":"20797602"}],"text":" that ACE2 activity may have some adverse effects on post-myocardial infarction heart [52]. The risk factors for cardiovascular disease include alterations in platelet function and coagulation with an increased risk of thrombosis. Ang II and hy"}